nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—ESR2—hindbrain—Parkinson's disease	0.0118	0.0645	CbGeAlD
Raloxifene—HTR6—forebrain—Parkinson's disease	0.00931	0.0508	CbGeAlD
Raloxifene—ESR1—hindbrain—Parkinson's disease	0.0081	0.0441	CbGeAlD
Raloxifene—ESR2—brainstem—Parkinson's disease	0.00677	0.0369	CbGeAlD
Raloxifene—ESR2—forebrain—Parkinson's disease	0.00654	0.0357	CbGeAlD
Raloxifene—ESR2—cardiovascular system—Parkinson's disease	0.00553	0.0302	CbGeAlD
Raloxifene—HTR6—head—Parkinson's disease	0.00533	0.0291	CbGeAlD
Raloxifene—CYP19A1—forebrain—Parkinson's disease	0.00515	0.0281	CbGeAlD
Raloxifene—ESR1—embryo—Parkinson's disease	0.00506	0.0276	CbGeAlD
Raloxifene—HTR6—nervous system—Parkinson's disease	0.00505	0.0276	CbGeAlD
Raloxifene—HTR2B—forebrain—Parkinson's disease	0.00505	0.0276	CbGeAlD
Raloxifene—HTR6—central nervous system—Parkinson's disease	0.00487	0.0265	CbGeAlD
Raloxifene—ESR1—brainstem—Parkinson's disease	0.00464	0.0253	CbGeAlD
Raloxifene—ESR1—forebrain—Parkinson's disease	0.00448	0.0244	CbGeAlD
Raloxifene—HTR2B—cardiovascular system—Parkinson's disease	0.00427	0.0233	CbGeAlD
Raloxifene—HTR6—brain—Parkinson's disease	0.00386	0.0211	CbGeAlD
Raloxifene—ESR1—cardiovascular system—Parkinson's disease	0.00379	0.0206	CbGeAlD
Raloxifene—ESR2—head—Parkinson's disease	0.00374	0.0204	CbGeAlD
Raloxifene—SIGMAR1—medulla oblongata—Parkinson's disease	0.00366	0.02	CbGeAlD
Raloxifene—ESR2—nervous system—Parkinson's disease	0.00355	0.0194	CbGeAlD
Raloxifene—ESR2—central nervous system—Parkinson's disease	0.00342	0.0186	CbGeAlD
Raloxifene—SIGMAR1—midbrain—Parkinson's disease	0.00335	0.0182	CbGeAlD
Raloxifene—ESR2—cerebellum—Parkinson's disease	0.00334	0.0182	CbGeAlD
Raloxifene—SIGMAR1—spinal cord—Parkinson's disease	0.00326	0.0178	CbGeAlD
Raloxifene—AOX1—cerebellum—Parkinson's disease	0.00321	0.0175	CbGeAlD
Raloxifene—CYP19A1—head—Parkinson's disease	0.00295	0.0161	CbGeAlD
Raloxifene—HTR2B—head—Parkinson's disease	0.00289	0.0158	CbGeAlD
Raloxifene—CYP2B6—cardiovascular system—Parkinson's disease	0.0028	0.0153	CbGeAlD
Raloxifene—CYP19A1—nervous system—Parkinson's disease	0.0028	0.0153	CbGeAlD
Raloxifene—HTR2B—nervous system—Parkinson's disease	0.00274	0.015	CbGeAlD
Raloxifene—ESR2—brain—Parkinson's disease	0.00271	0.0148	CbGeAlD
Raloxifene—CYP19A1—central nervous system—Parkinson's disease	0.00269	0.0147	CbGeAlD
Raloxifene—HTR2B—central nervous system—Parkinson's disease	0.00264	0.0144	CbGeAlD
Raloxifene—AOX1—brain—Parkinson's disease	0.00261	0.0142	CbGeAlD
Raloxifene—SIGMAR1—cerebellum—Parkinson's disease	0.00259	0.0141	CbGeAlD
Raloxifene—ESR1—head—Parkinson's disease	0.00256	0.014	CbGeAlD
Raloxifene—ESR1—nervous system—Parkinson's disease	0.00243	0.0133	CbGeAlD
Raloxifene—ESR1—central nervous system—Parkinson's disease	0.00234	0.0128	CbGeAlD
Raloxifene—ESR1—cerebellum—Parkinson's disease	0.00229	0.0125	CbGeAlD
Raloxifene—CYP19A1—brain—Parkinson's disease	0.00214	0.0117	CbGeAlD
Raloxifene—SIGMAR1—brain—Parkinson's disease	0.0021	0.0115	CbGeAlD
Raloxifene—HTR2B—brain—Parkinson's disease	0.0021	0.0114	CbGeAlD
Raloxifene—CYP2B6—head—Parkinson's disease	0.00189	0.0103	CbGeAlD
Raloxifene—ESR1—brain—Parkinson's disease	0.00186	0.0101	CbGeAlD
Raloxifene—CYP2B6—nervous system—Parkinson's disease	0.0018	0.0098	CbGeAlD
Raloxifene—CYP2B6—central nervous system—Parkinson's disease	0.00173	0.00943	CbGeAlD
Raloxifene—CYP2C8—brain—Parkinson's disease	0.00153	0.00835	CbGeAlD
Raloxifene—CYP2B6—brain—Parkinson's disease	0.00137	0.00749	CbGeAlD
Raloxifene—CYP3A4—nervous system—Parkinson's disease	0.00136	0.0074	CbGeAlD
Raloxifene—CYP3A4—central nervous system—Parkinson's disease	0.00131	0.00712	CbGeAlD
Raloxifene—CYP2B6—Metabolism—NDUFB11—Parkinson's disease	0.000326	0.000399	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PENK—Parkinson's disease	0.000322	0.000394	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAG—Parkinson's disease	0.000322	0.000394	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—DRD3—Parkinson's disease	0.000321	0.000393	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—DRD3—Parkinson's disease	0.00032	0.000391	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HTR7—Parkinson's disease	0.000318	0.00039	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—DRD2—Parkinson's disease	0.000318	0.00039	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000318	0.000389	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—DDC—Parkinson's disease	0.000316	0.000388	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HTR1A—Parkinson's disease	0.000312	0.000382	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GCH1—Parkinson's disease	0.000311	0.00038	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GRM4—Parkinson's disease	0.00031	0.000379	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ND3—Parkinson's disease	0.000309	0.000379	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MCCC1—Parkinson's disease	0.000309	0.000379	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	0.000309	0.000378	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—TAC1—Parkinson's disease	0.000307	0.000376	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000305	0.000373	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RIT2—Parkinson's disease	0.000303	0.000372	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—DRD1—Parkinson's disease	0.000301	0.000369	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—RPL14—Parkinson's disease	0.000301	0.000368	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—RPL23A—Parkinson's disease	0.000301	0.000368	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.0003	0.000367	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GSTA4—Parkinson's disease	0.000299	0.000366	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000298	0.000365	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.000295	0.000361	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PDYN—Parkinson's disease	0.000294	0.00036	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PENK—Parkinson's disease	0.000294	0.00036	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAG—Parkinson's disease	0.000294	0.00036	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—DRD3—Parkinson's disease	0.000292	0.000357	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—TALDO1—Parkinson's disease	0.000291	0.000356	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—OMD—Parkinson's disease	0.000291	0.000356	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—DRD2—Parkinson's disease	0.00029	0.000356	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HTR7—Parkinson's disease	0.00029	0.000356	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—COMT—Parkinson's disease	0.00029	0.000355	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HTR7—Parkinson's disease	0.000289	0.000354	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—DRD2—Parkinson's disease	0.000289	0.000354	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GSTP1—Parkinson's disease	0.000289	0.000354	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—MAOA—Parkinson's disease	0.000288	0.000353	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GRK5—Parkinson's disease	0.000288	0.000352	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—HMOX1—Parkinson's disease	0.000285	0.000349	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—RPS8—Parkinson's disease	0.00028	0.000343	CbGpPWpGaD
Raloxifene—AOX1—Disease—MTHFR—Parkinson's disease	0.00028	0.000343	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—FBP1—Parkinson's disease	0.000277	0.000339	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GBA—Parkinson's disease	0.000277	0.000339	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—DBH—Parkinson's disease	0.000277	0.000339	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GFAP—Parkinson's disease	0.000277	0.000339	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	0.000276	0.000338	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GRM5—Parkinson's disease	0.000274	0.000335	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ABCB1—Parkinson's disease	0.000273	0.000335	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000272	0.000333	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PLA2G6—Parkinson's disease	0.000269	0.000329	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PDYN—Parkinson's disease	0.000269	0.000329	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—MAOB—Parkinson's disease	0.000266	0.000326	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GSTM1—Parkinson's disease	0.000265	0.000325	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—DRD2—Parkinson's disease	0.000264	0.000323	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HTR7—Parkinson's disease	0.000264	0.000323	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GCH1—Parkinson's disease	0.000263	0.000322	CbGpPWpGaD
Raloxifene—AOX1—Disease—APOE—Parkinson's disease	0.000261	0.000319	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GRM4—Parkinson's disease	0.000258	0.000316	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—COMT—Parkinson's disease	0.000256	0.000314	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	0.000255	0.000312	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—EDN1—Parkinson's disease	0.000255	0.000312	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	0.000254	0.000311	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GPX1—Parkinson's disease	0.000254	0.000311	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000254	0.00031	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	0.000252	0.000309	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GFAP—Parkinson's disease	0.000252	0.000309	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000251	0.000308	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000251	0.000308	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GRM5—Parkinson's disease	0.00025	0.000306	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAG—Parkinson's disease	0.000245	0.0003	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PENK—Parkinson's disease	0.000245	0.0003	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—IL6—Parkinson's disease	0.000244	0.000298	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGF20—Parkinson's disease	0.00024	0.000294	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	0.000237	0.00029	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—MTHFR—Parkinson's disease	0.000235	0.000287	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GBA—Parkinson's disease	0.000234	0.000287	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—FBP1—Parkinson's disease	0.000234	0.000287	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—DBH—Parkinson's disease	0.000234	0.000287	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	0.000234	0.000287	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ADORA2A—Parkinson's disease	0.000233	0.000285	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—EDN1—Parkinson's disease	0.000233	0.000285	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—EDN1—Parkinson's disease	0.000231	0.000283	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000231	0.000283	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—HSPA8—Parkinson's disease	0.000225	0.000275	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—CTGF—Parkinson's disease	0.000224	0.000274	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PDYN—Parkinson's disease	0.000224	0.000274	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000223	0.000273	CbGpPWpGaD
Raloxifene—AOX1—Disease—INS—Parkinson's disease	0.000223	0.000273	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000222	0.000271	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGF20—Parkinson's disease	0.000219	0.000268	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—APOE—Parkinson's disease	0.000218	0.000267	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—INSR—Parkinson's disease	0.000215	0.000263	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ADORA2A—Parkinson's disease	0.000212	0.00026	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—EDN1—Parkinson's disease	0.000211	0.000259	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GFAP—Parkinson's disease	0.00021	0.000258	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GRM5—Parkinson's disease	0.000208	0.000255	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—HSPA1A—Parkinson's disease	0.000205	0.000251	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000203	0.000249	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—DDC—Parkinson's disease	0.000203	0.000249	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGB—Parkinson's disease	0.000203	0.000248	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—HTR2A—Parkinson's disease	0.000202	0.000248	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR1A—Parkinson's disease	0.000202	0.000247	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TAC1—Parkinson's disease	0.000199	0.000243	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP2D6—Parkinson's disease	0.000198	0.000242	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—INSR—Parkinson's disease	0.000196	0.00024	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—DRD1—Parkinson's disease	0.000195	0.000239	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CTGF—Parkinson's disease	0.000194	0.000238	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTA4—Parkinson's disease	0.000192	0.000235	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—DRD3—Parkinson's disease	0.000189	0.000231	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—INS—Parkinson's disease	0.000187	0.000228	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGB—Parkinson's disease	0.000185	0.000227	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—HTR2A—Parkinson's disease	0.000185	0.000226	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR1A—Parkinson's disease	0.000184	0.000226	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGF20—Parkinson's disease	0.000182	0.000223	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TAC1—Parkinson's disease	0.000181	0.000222	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP2E1—Parkinson's disease	0.000181	0.000222	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—NQO1—Parkinson's disease	0.000179	0.000219	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—DRD1—Parkinson's disease	0.000178	0.000218	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000177	0.000217	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—TH—Parkinson's disease	0.000176	0.000216	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ADRBK1—Parkinson's disease	0.000176	0.000216	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	0.000173	0.000212	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—DRD3—Parkinson's disease	0.000172	0.000211	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—DDC—Parkinson's disease	0.000172	0.000211	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MAOB—Parkinson's disease	0.000171	0.000209	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—DRD2—Parkinson's disease	0.000171	0.000209	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR7—Parkinson's disease	0.000171	0.000209	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYCS—Parkinson's disease	0.000169	0.000207	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ND3—Parkinson's disease	0.000166	0.000203	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MCCC1—Parkinson's disease	0.000166	0.000203	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—INSR—Parkinson's disease	0.000163	0.0002	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTA4—Parkinson's disease	0.000162	0.000199	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ADRBK1—Parkinson's disease	0.000161	0.000197	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	0.00016	0.000196	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—OMD—Parkinson's disease	0.000156	0.000191	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TALDO1—Parkinson's disease	0.000156	0.000191	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR7—Parkinson's disease	0.000156	0.000191	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—DRD2—Parkinson's disease	0.000156	0.000191	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGB—Parkinson's disease	0.000154	0.000189	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR1A—Parkinson's disease	0.000153	0.000188	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TAC1—Parkinson's disease	0.000151	0.000185	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—COMT—Parkinson's disease	0.00015	0.000184	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GSTP1—Parkinson's disease	0.000149	0.000183	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—MAOA—Parkinson's disease	0.000149	0.000182	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—DRD1—Parkinson's disease	0.000148	0.000181	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	0.000148	0.000181	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—HMOX1—Parkinson's disease	0.000147	0.00018	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	0.000146	0.000179	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MAOB—Parkinson's disease	0.000145	0.000177	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—DRD3—Parkinson's disease	0.000144	0.000176	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IGF2—Parkinson's disease	0.000143	0.000175	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ABCB1—Parkinson's disease	0.000141	0.000173	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GCH1—Parkinson's disease	0.000141	0.000173	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IGF1R—Parkinson's disease	0.000138	0.000169	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	0.000138	0.000169	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GSTM1—Parkinson's disease	0.000137	0.000168	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EDN1—Parkinson's disease	0.000137	0.000167	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000134	0.000164	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GPX1—Parkinson's disease	0.000131	0.000161	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IGF2—Parkinson's disease	0.000131	0.00016	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—DRD2—Parkinson's disease	0.00013	0.000159	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR7—Parkinson's disease	0.00013	0.000159	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	0.000127	0.000156	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IGF1R—Parkinson's disease	0.000126	0.000155	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GBA—Parkinson's disease	0.000126	0.000154	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—DBH—Parkinson's disease	0.000126	0.000154	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—FBP1—Parkinson's disease	0.000126	0.000154	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NGF—Parkinson's disease	0.000126	0.000154	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CTGF—Parkinson's disease	0.000125	0.000153	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EDN1—Parkinson's disease	0.000125	0.000153	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—MTHFR—Parkinson's disease	0.000121	0.000148	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HTR2A—Parkinson's disease	0.00012	0.000146	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	0.000116	0.000142	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—NQO1—Parkinson's disease	0.000115	0.000141	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NGF—Parkinson's disease	0.000115	0.00014	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—TH—Parkinson's disease	0.000113	0.000139	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—APOE—Parkinson's disease	0.000113	0.000138	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—APOE—Parkinson's disease	0.000111	0.000136	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HTR2A—Parkinson's disease	0.000109	0.000134	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYCS—Parkinson's disease	0.000109	0.000133	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IGF2—Parkinson's disease	0.000109	0.000133	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	0.000108	0.000132	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CTGF—Parkinson's disease	0.000106	0.000129	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IGF1R—Parkinson's disease	0.000105	0.000129	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EDN1—Parkinson's disease	0.000104	0.000127	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APOE—Parkinson's disease	0.000101	0.000124	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	9.84e-05	0.000121	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—NQO1—Parkinson's disease	9.73e-05	0.000119	CbGpPWpGaD
Raloxifene—AOX1—Disease—IL6—Parkinson's disease	9.73e-05	0.000119	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—INS—Parkinson's disease	9.64e-05	0.000118	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—COMT—Parkinson's disease	9.63e-05	0.000118	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—TH—Parkinson's disease	9.59e-05	0.000117	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTP1—Parkinson's disease	9.59e-05	0.000117	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MAOA—Parkinson's disease	9.57e-05	0.000117	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NGF—Parkinson's disease	9.55e-05	0.000117	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—INS—Parkinson's disease	9.5e-05	0.000116	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—HMOX1—Parkinson's disease	9.46e-05	0.000116	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—DDC—Parkinson's disease	9.23e-05	0.000113	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYCS—Parkinson's disease	9.21e-05	0.000113	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HTR2A—Parkinson's disease	9.09e-05	0.000111	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ABCB1—Parkinson's disease	9.08e-05	0.000111	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GSTM1—Parkinson's disease	8.81e-05	0.000108	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTA4—Parkinson's disease	8.72e-05	0.000107	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—INS—Parkinson's disease	8.67e-05	0.000106	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APOE—Parkinson's disease	8.45e-05	0.000103	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GPX1—Parkinson's disease	8.44e-05	0.000103	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—COMT—Parkinson's disease	8.16e-05	9.99e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTP1—Parkinson's disease	8.12e-05	9.94e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MAOA—Parkinson's disease	8.1e-05	9.92e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—HMOX1—Parkinson's disease	8.01e-05	9.8e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	7.85e-05	9.62e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MTHFR—Parkinson's disease	7.79e-05	9.54e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MAOB—Parkinson's disease	7.77e-05	9.52e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ABCB1—Parkinson's disease	7.68e-05	9.41e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GSTM1—Parkinson's disease	7.46e-05	9.14e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—APOE—Parkinson's disease	7.25e-05	8.88e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—INS—Parkinson's disease	7.22e-05	8.84e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GPX1—Parkinson's disease	7.14e-05	8.75e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CASP3—Parkinson's disease	7.07e-05	8.66e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6—Parkinson's disease	7.02e-05	8.6e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MTHFR—Parkinson's disease	6.59e-05	8.07e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	6.5e-05	7.96e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CASP3—Parkinson's disease	6.45e-05	7.9e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6—Parkinson's disease	6.41e-05	7.85e-05	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—INS—Parkinson's disease	6.19e-05	7.58e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—APOE—Parkinson's disease	6.14e-05	7.52e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MAPK8—Parkinson's disease	5.93e-05	7.26e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	5.78e-05	7.07e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CTGF—Parkinson's disease	5.67e-05	6.94e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CASP3—Parkinson's disease	5.38e-05	6.58e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	5.28e-05	6.47e-05	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—INS—Parkinson's disease	5.24e-05	6.42e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—NQO1—Parkinson's disease	5.22e-05	6.4e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TH—Parkinson's disease	5.15e-05	6.31e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYCS—Parkinson's disease	4.94e-05	6.05e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MAPK8—Parkinson's disease	4.94e-05	6.05e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—COMT—Parkinson's disease	4.38e-05	5.36e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTP1—Parkinson's disease	4.36e-05	5.34e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MAOA—Parkinson's disease	4.35e-05	5.32e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—HMOX1—Parkinson's disease	4.3e-05	5.26e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6—Parkinson's disease	4.15e-05	5.08e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ABCB1—Parkinson's disease	4.12e-05	5.05e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GSTM1—Parkinson's disease	4e-05	4.9e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.83e-05	4.7e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6—Parkinson's disease	3.79e-05	4.64e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MTHFR—Parkinson's disease	3.54e-05	4.33e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—APOE—Parkinson's disease	3.29e-05	4.03e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6—Parkinson's disease	3.15e-05	3.86e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—INS—Parkinson's disease	2.81e-05	3.45e-05	CbGpPWpGaD
